The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance

The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance.

Communicating to patients and healthcare providers about the risks of harm with medicines and how to use medicines safely is vital to pharmacovigilance for fulfilling its objectives—there is no or little risk avoidance/mitigation or patient safety without risk communication. Communication about risk characteristics and factors should also enable patients and healthcare providers to make informe...

analysis of power in the network society

اندیشمندان و صاحب نظران علوم اجتماعی بر این باورند که مرحله تازه ای در تاریخ جوامع بشری اغاز شده است. ویژگیهای این جامعه نو را می توان پدیده هایی از جمله اقتصاد اطلاعاتی جهانی ، هندسه متغیر شبکه ای، فرهنگ مجاز واقعی ، توسعه حیرت انگیز فناوری های دیجیتال، خدمات پیوسته و نیز فشردگی زمان و مکان برشمرد. از سوی دیگر قدرت به عنوان موضوع اصلی علم سیاست جایگاه مهمی در روابط انسانی دارد، قدرت و بازتولید...

Pharmacovigilance in the 1990s.

Since the thalidomide disaster brought the risks of drug events usually refer to general practitioner contacts, outpatient contacts, hospitalization or deaths. This approach therapy into sharp focus, efforts have been made to establish observational systems for early detection of possible adverse was first mooted by Finney in Edinburgh as far back as 1965 [10], but had to await the advent of po...

Forensic pharmacovigilance.

New Approaches in Pharmacovigilance in the Pharmacogenomic Era: A Call for Papers

The presentation of the most recent developments in the field of drug safety falls very well within the scope of the Journal of Pharmacovigilance: pharmacogenetics is certainly one of these. It is the study of associations of genetic traits of individuals and their response to drugs and has become an important aspect to be considered both during drug development and in post-marketing surveillan...